The consequences of the coronavirus disease (COVID-19) outbreak are unprecedented and felt around the world. Industries are being profoundly affected by the pandemic. Fortunately, BiOptic Inc. remains high productivity and keeps devoted to technological innovation. The outstanding R&D capabilities allow us to win several Technology Development Program (TDP) from the government and were favored by the committee of Taipei Biotech Awards – Innovation Award in July 2020.
Are you still using traditional spectrophotometry for nucleic acid quantitation?
BiOptic Quantitative Cartridge Kits
• Quantitative Standard Cartridge Kit (C105201-Q)
• Quantitative High-Resolution Cartridge Kit (C105202-Q)
Celebration! Received the Republic of China Invention cetification No. I657138
2019-04-21
BiOptic Inc. has been dedicated in R&D for many years, developing molecular biology and genetic analysis technologies, and creating products for modern genomics research.
